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Abstract  
BACKGROUND: Acute bacterial rhinosinusitis is one of upper respiratory tract infection that disturbs patient life 
and requires special consideration. 
AIM: To evaluate the efficiency of Ceftriaxone versus a high dose of Amoxicillin-clavulanic acid for the treatment 
of acute bacterial rhinosinusitis. 
PATIENTS AND METHOD: Observational retrospective study include120 patients of both sex classified into two 
groups equally conducted. G1 treated with Ceftriaxone 1 g intramuscular injection once daily while, G2 treated 
with oral Amoxicillin-clavulanic acid (875 mg/125 mg) twice daily for 3-4 days then, the outcome of treatment 
evaluated as a cure or failed at the fifth or fourth day of treatment. 
RESULTS: Significant cure response observed in Ceftriaxone treated patient's P ≤ 0.05 and significant failure 
response observed in Amoxicillin-clavulanic acid-treated patients when groups compared with each other. About 
gender and age groups, no significant differences in number between group 1 and 2 P ≥ 0.05. 
CONCLUSION: Ceftriaxone found more effective in the treatment of acute bacterial sinusitis than Amoxicillin+ 
clavulanic acid. Amoxicillin+clavulanic acid associated with more male failure cases recorded than female. 
 
 
 
 
 
 
 
 
 
Introduction 
 
Rhinosinusitis is an inflammation of the lining 
epithelia of paranasal sinuses and nasal cavity 
associated with nasal purulent secretion [1] [2]. 
Rhinosinusitis classified to acute and chronic infection 
according to the duration of symptoms and to viral and 
bacterial rhinosinusitis depending on the causative 
source [3]. Symptoms are nasal congestion, purulent 
secretion, facial pain or pressure, pain on bending 
forward, upper teeth pain, fever and headache [4][5]. 
Acute rhinosinusitis among the principal cause to 
millions of physician visits every year [5]. The 
common cold is the common upper respiratory tract 
disease that could be complicated with bacterial 
infection leading to acute bacterial rhinosinusitis [2] 
[6]. 
The inability of clinical criteria to distinguish 
between viral and bacterial rhinosinusitis cause 
inappropriate, excessive antibiotics prescription [6] [7]. 
Although most of the rhinosinusitis is of viral 
cause and self-limiting if symptoms persist for more 
than 10 days or worsen within 7 days regarded as 
acute bacterial rhinosinusitis [8]. According to that 
strategy of treatment changed to involve antibiotic 
treatments, topical corticosteroids, analgesics and/or 
decongestants [9]. 
However, proper antibiotics choice and 
duration are of great interest. Chose antibiotic 
prescription to depend on bacterial species, including 
Streptococcus pneumoniae, Haemophilus inﬂuenzae 
and, particularly in children, Moraxella catarrhalis [10]. 
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Guidelines of treatment suggest Amoxicillin-
clavulanate as a first-line empiric antibiotic for mild 
rhino sinusitis short course treatment [11] [12]. In case 
of no improvement or penicillin sensitivity Amoxicillin-
clavulanate dose either increased or another antibiotic 
selected like respiratory fluoroquinolone such as 
moxifloxacin, levofloxacin or cephalosporin's [12] [13].  
Ceftriaxone is third-generation cephalosporin 
with strong wide range antibacterial profile, its β-
lactam antibiotic act by inhibition of bacterial cell wall 
synthesis. Ceftriaxone half-life about eight hours 
allows single daily dose for treatment of infections 
caused by various bacterial species like Klebsiella, 
Providencia, Serratia, and Haemophilus species. It is 
the drug of choice for meningitis caused by 
Haemophilus influenza. Adverse reaction of 
Ceftriaxone is hypersensitivity responses that are 
indistinguishable from those of penicillin [14]. 
 Previous studies show that Ceftriaxone is 
good replacements for amoxicillin in the treatment of 
acute tonsillopharyngitis due to its safety [15].  
The current study aims to evaluate the 
efficiency of Ceftriaxone versus oral Amoxicillin-
clavulanic acid for the treatment of acute bacterial 
rhinosinusitis. 
 
 
Patients and Method  
 
A retrospective observational study conducted 
in (ear, nose and throat) ENT consultant clinic of our 
teaching hospital at a period from October 2016 to 
December 2017 for patients diagnosed with acute 
bacterial rhinosinusitis under the approval of a 
responsible, ethical committee of surgical department  
A group of 120 patients of both sexes with 
age 15-52 years attend ENT consultant clinic suffering 
from facial pain and pressure, nasal obstruction with 
purulent discharge (rhinorrhoea) and fever after flu-
like reaction for more than 10 days included according 
to Infectious Disease Society of America (IDSA) 
guidelines [12]. 
Patients with a history of flu-like illness 
without complication within the first 7 days, patients 
with previous surgery on nasal sinuses, patients with 
diabetes mellitus or renal impairment, patients with 
allergy to penicillin groups or ceftriaxone, patients with 
traumatic nasal injury, and symptoms duration more 
than 12 weeks excluded. 
All patients included clinically examined by 
nasal endoscope finding the followings: 
Nasal septal deviation, bilateral hypertrophy 
of inferior turbinate, pus discharge from middle 
meatus with red nasal mucosa and postnasal drip 
(mucus pus), then sent to computerised coronal 
tomography to ensure no complications. 
Patients with a positive sign and symptoms of 
acute bacterial rhinosinusitis treated as the following: 
Group 1: 60 patients prescribed with 
Ceftriaxone 1g intramuscular injection every 24 hours. 
Group 2: 60 patients prescribed with 
Amoxicillin-clavulanic acid orally 1000 mg (875 
mg/125 mg) every 12 hours for 3-4 days. 
Xylometazoline nasal decongestant and 
analgesia prescribed for both groups.  
After antibiotic regimen, patients followed up 
on the fifth day to evaluate the following: 
1 - cure: no sign and symptoms of acute 
bacterial rhinosinusitis clinically. 
2 - failure: persistence of sign and symptoms 
of acute bacterial rhinosinusitis clinically or 
complicated. 
3 - an adverse reaction to the antibiotic 
regimen. 
(Amoxicillin + clavulanic acid) oral tablet 1000 
mg (875 mg/125 mg) (Comox Acino, Acino Pharma., 
Switzerland). 
Ceftriaxone vial for intravenous /intramuscular 
injection 1 g (TORLAN, Spain). 
Data presented by the proportion of the total 
number. Statistical significant assessed by Fisher 
exact test at the level of ≤ 0.05 using SPSS version 21 
from IBM.  
 
 
Results  
 
The current study results show patients 
treated with Ceftriaxone for short course treatment 
have significantly higher cure proportion than those 
treated with (Amoxicillin + clavulanic acid) during 
follow up period, P ≤ 0.05, Table 1. 
Table 1: Response to treatments among groups 
Treatments  Patients 
number 
Gender 
Male           Female 
Cure cases Failure cases 
Ceftriaxone 
G1 
60 34 (55.9%) 26 (44.06%) 
 
50 (83.33%)* 10 (16.66%) 
(Amoxillin/clavulanic 
acid)  G2 
60 32 (53.3%) 28 (46.6%) 39 (65%) 21 (35%)* 
 
*p ≤ 0.05. 
 
By gender, no significant differences in 
number between group 1 and 2, P ≥ 0.05. Cure cases 
about the gender of Ceftriaxone treated group show 
higher proportion among male than female, Table 2. 
 While in-group 2 the proportions of male and 
female were comparable in cure response, Table 3. 
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On the other hand, failure of treatment was 
more in male than female in group 2, Table 3. 
About age group, no differences in numbers 
of patients observed between treatments groups, 
Table 2 and 3. 
Table 2: Response to treatments of group 1 about gender and 
age group 
Age group Male Female 
20-30 years 
30-40 
40-60 
25 (42.3%) 
5 (8.47%) 
3 (5%) 
19 (31.66%) 
5 (8.47%) 
3 (5%) 
Cure cases 27 (81.8%) 23 (84.61%) 
Failure cases 6 (18.18%) 4 (15.38%) 
 
Three patients develop skin rash adverse 
reaction to Ceftriaxone while only one patient develop 
a skin reaction to Amoxicillin+ clavulanic acid 
treatment recorded during the study period. 
 Failure cases treated by the change of 
antibiotic regimen or surgical treatment for those 
complicated during the study period according to 
clinical examination at follow up visit.  
Table 3: Response to treatments of group 2 about gender and 
age group 
Age group Male Female 
20-30 years 
30-40 
40-60 
21 (35%) 
8 (13.3%) 
3 (5%) 
19(31%) 
6(10%) 
3(5%) 
Cure cases 19 (59.37%) 20(71.4%) 
Failure cases 13 (40.6%) 8(28.57%) 
 
 
Discussion 
 
Acute bacterial rhinosinusitis among the 
higher complaints of patients attends ENT outpatient 
clinics in our region. It disturbs the patient's normal life 
with serious complication if not treated properly [16]. 
The current study was a retrospective 
observational study that aimed to evaluate the 
response of patients with acute bacterial rhinosinusitis 
to two regimens of antibiotics including first-line oral 
(Amoxicillin + clavulanic acid) drug in high dose and 
Ceftriaxone. 
Short antibiotic treatment decided to avoid an 
adverse reaction, development of bacterial resistance 
and decrease cost; depending on previous studies 
that found no dependable differences in response 
between short and long antibiotic treatment [12] [17].  
The choice of Ceftriaxone was following 
recent guidelines that suggest β-lactam agent rather 
than a respiratory fluoroquinolone for empiric 
antimicrobial therapy [12]. 
Beside to Ceftriaxone efficiency against 
Haemophilus species and other pathogenic bacteria 
which are mostly isolated species from swaps of acute 
bacterial rhinosinusitis patients and its recorded safety 
for short course treatments that decrease patients 
hospitalisation and cost [18]. 
The study results show significant high cure 
response to Ceftriaxone than (Amoxicillin + clavulanic 
acid) as observed at the end of 3-4 days of treatments 
according to guidelines of short course antibiotic 
treatments. This result proves the efficiency of 
Ceftriaxone for acute bacterial rhinosinusitis. Although 
its parenteral drug, it's well tolerated with broad 
spectrum efficiency that made Ceftriaxone good 
alternative antibiotic. This explanation goes with 
Seaton and Barr [18] study that evaluate outpatient 
parenteral antibiotic therapy to decrease hospital 
admission and cost. Also, agree with Duncan and 
colleague study [15] that found Ceftriaxone excellent 
broad-spectrum antibiotic for various clinical infection 
states including upper respiratory tract infection. 
Moreover, high failure response to 
(Amoxicillin + clavulanic acid) observed in this study 
even though it regarded as the first-line drug for acute 
bacterial rhinosinusitis could be explained by the 
development of non B- lactamase type of resistance in 
certain pathogenic species like Streptococcus 
pneumonia making Ceftriaxone more efficient 
replacement [19] [20]. 
However, it required future microbiological 
study to look for the most common causative 
microorganism for acute bacterial rhinosinusitis in our 
region.  
This finding unlike Muhammad and colleague 
[21] finding that demonstrate the effectiveness of high 
dose Amoxicillin + clavulanic acid in the treatment of 
acute bacterial rhinosinusitis as compared to 
levofloxacin for 10 days treatment, Which may be due 
to the dissimilarity of treatment period that lasts for 3-4 
days in the current study. 
About gender response to treatment, male 
treated with Ceftriaxone show more resolution of 
symptoms (cure) as compared to female patients, that 
probably due to differences in some included cases. 
While, in group 2, male patients show more failure 
response than the female of the same group that 
could be due to the variation of an inhabitant of a 
respiratory microorganism or due to variation in 
immune response and tolerance between male and 
female [22] [23].  
The antibiotic-related adverse reaction was 
predicted for the types of antibiotic used with more 
adverse reaction recorded in group 1 [24] although, it 
is not serious reactions. 
Nasal decongestant and analgesics 
prescribed for both treatment groups to decrease 
nasal obstruction and relief painful symptoms 
associated with acute bacterial rhinosinusitis.  
In conclusion, Ceftriaxone found to be more 
effective than Amoxicillin + clavulanic acid in the 
treatment of acute bacterial sinusitis. Amoxicillin + 
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clavulanic acid associated with more male failure 
cases than female. 
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